Category: therapies
-
NMDP BioTherapies To Present Data at ISCT 2024 on the Stability of Infectious Disease Marker Analytes During Donor Qualification for Allogeneic Cell Therapies
•
Article content The study, jointly conducted by researchers from Labor Quade and Johns Hopkins University School of Medicine, analyzed the long-term stability of IDM analytes in non-centrifuged peripheral blood samples to allow for increased flexibility in processing donor samples. The study results indicate that the widespread use of blood processing…